Company Overview and News

 
Long Dish Network: Undervalued Spectrum Implies Vast Upside

1h seekingalpha
Market view has been depressed due to deterioration within the pay-TV industry, paving the way for an excellent entry point.
Upvote Downvote

 
AT&T, Verizon Face U.S. Probe Over Mobile Technology - Bloomberg

2h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Interest-rate worries may not be offset by good earnings news in the week ahead

2h cnbc
Rising interest rates and inflation worries could hang over the stock market in the coming week, as investors look to a big flood of earnings news to lift some of their anxiety.
Upvote Downvote

 
Comcast Bid 16% More Than Disney for 21st Century Fox, Filing Shows - The New York Times

2h nytimes
LOS ANGELES — Rupert Murdoch sold most of 21st Century Fox to Disney in December for $52.4 billion, spurning a proposal from Comcast that was 16 percent higher on a per-share basis, in part because Comcast refused to offer protections in the event of regulatory rejection.
Upvote Downvote

 
Report: Justice Deptartment investigating AT&T, Verizon

2h nzherald.co.nz
NEW YORK (AP) — The Justice Department has opened an antitrust investigation into whether AT&T, Verizon and a standards-setting group worked together to stop consumers from easily switching wireless carriers.
Upvote Downvote

 
US said to investigate AT&T, Verizon over wireless collusion claim: source

3h channelnewsasia
The U.S. Justice Department has opened an antitrust probe into potential coordination by AT&T , Verizon and a telecommunications standards organization to hinder consumers from easily switching wireless carriers, the New York Times reported on Friday, citing six people with knowledge of the inquiry.
Upvote Downvote

 
AT&T, Verizon Shares Slip on Report of Justice Department Probe - Bloomberg

3h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
AT&T Accused of Stealing Streaming-News Technology System - Bloomberg

4h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
US said to investigate AT&T and Verizon over wireless collusion claim

4h cnbc
The Justice Department has opened an antitrust investigation into potential coordination by AT&T, Verizon and a telecommunications standards organization to hinder consumers from easily switching wireless carriers, according to six people with knowledge of the inquiry.
Upvote Downvote

 
U.S. Said to Investigate AT&T and Verizon Over Wireless Collusion Claim - The New York Times

4h nytimes
WASHINGTON — The Justice Department has opened an antitrust investigation into potential coordination by AT&T, Verizon and a telecommunications standards organization to hinder consumers from easily switching wireless carriers, according to six people with knowledge of the inquiry.
Upvote Downvote

1
My 7 Must-Own Stocks to Build Up Your Retirement

8h investorplace
I have a completely different philosophy for retirement stocks than virtually anybody else in the financial markets.
Upvote Downvote

 
Deals of the day-Mergers and acquisitions

13h reuters
April 20 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Friday: ** Several assets of German energy firm Innogy have attracted the interest of an outside investor, the group said on Friday, a month after parent RWE disclosed plans to break up the group with rival E.ON. ** Financial software firm Ion Group Investment has made a $2.1 billion bid for Britain’s Fidessa, potentially gatecrashing a takeover of the London-listed company by Swiss banking software supplier Temenos.
Upvote Downvote

 
6 Most Important Things In Business Today

15h 247wallst
Mattel Inc.Chief Executive Margo Georgiadis is leaving the toy maker after about a year in the job, a surprising shake-up at a company searching for a strategy that can end a four-year sales slump.
Upvote Downvote

 
Flash - AT&T chief says merger would boost value of Time Warner - France 24

15h france24
AT&T chief Randall Stephenson on Thursday defended his company's planned mega-merger with Time Warner, arguing in court that the combination would enhance the value of the media-entertainment giant in a sector being roiled by Big Tech.
Upvote Downvote

 
AT&T planning low-cost ‘skinny bundle’ streaming service - MarketWatch

21h marketwatch
AT&T Inc. plans to launch a “skinny bundle” of television channels without sports that will cost $15 a month, one of the lowest prices available for a nationwide streaming live TV plan.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 88732J207